| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| nef Gene Products, Human Immunodeficiency Virus | 12 | 2025 | 59 | 3.340 |
Why?
|
| HIV-1 | 31 | 2025 | 755 | 3.200 |
Why?
|
| Peptides | 9 | 2026 | 372 | 2.660 |
Why?
|
| Exosomes | 9 | 2020 | 126 | 2.160 |
Why?
|
| HIV Infections | 16 | 2025 | 2586 | 1.370 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2025 | 57 | 1.360 |
Why?
|
| Receptors, CXCR4 | 10 | 2024 | 74 | 1.190 |
Why?
|
| Vimentin | 3 | 2025 | 44 | 1.120 |
Why?
|
| MicroRNAs | 4 | 2026 | 518 | 1.120 |
Why?
|
| Apoptosis | 17 | 2019 | 1568 | 1.100 |
Why?
|
| Breast Neoplasms | 4 | 2025 | 1723 | 1.020 |
Why?
|
| HIV Envelope Protein gp120 | 11 | 2025 | 54 | 1.020 |
Why?
|
| Gene Products, nef | 6 | 2015 | 19 | 0.870 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 67 | 0.770 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 67 | 0.770 |
Why?
|
| Acquired Immunodeficiency Syndrome | 4 | 2023 | 226 | 0.740 |
Why?
|
| Peptide Fragments | 5 | 2015 | 307 | 0.680 |
Why?
|
| Inflammation | 1 | 2026 | 758 | 0.650 |
Why?
|
| Cytokines | 3 | 2026 | 678 | 0.600 |
Why?
|
| Humans | 60 | 2026 | 43102 | 0.590 |
Why?
|
| Extracellular Space | 3 | 2014 | 36 | 0.560 |
Why?
|
| Endothelium, Vascular | 5 | 2009 | 263 | 0.560 |
Why?
|
| Clusterin | 1 | 2017 | 9 | 0.520 |
Why?
|
| Cell Line, Tumor | 7 | 2026 | 2676 | 0.520 |
Why?
|
| Receptors, CCR5 | 4 | 2001 | 64 | 0.500 |
Why?
|
| Protein Binding | 4 | 2025 | 1082 | 0.490 |
Why?
|
| Molecular Sequence Data | 14 | 2012 | 1542 | 0.470 |
Why?
|
| Cell Line | 16 | 2025 | 1410 | 0.420 |
Why?
|
| Momordica | 2 | 2023 | 14 | 0.390 |
Why?
|
| T-Lymphocytes | 3 | 2025 | 386 | 0.380 |
Why?
|
| Amino Acid Sequence | 11 | 2012 | 1180 | 0.380 |
Why?
|
| Macrophages | 2 | 2020 | 529 | 0.380 |
Why?
|
| Sequence Analysis, Protein | 1 | 2012 | 52 | 0.370 |
Why?
|
| Transfection | 8 | 2013 | 532 | 0.360 |
Why?
|
| HIV Seropositivity | 3 | 2022 | 196 | 0.350 |
Why?
|
| Anti-HIV Agents | 4 | 2025 | 486 | 0.320 |
Why?
|
| Cells, Cultured | 10 | 2016 | 1621 | 0.320 |
Why?
|
| Transport Vesicles | 1 | 2010 | 22 | 0.320 |
Why?
|
| Chemokine CXCL10 | 4 | 2015 | 38 | 0.310 |
Why?
|
| Models, Molecular | 2 | 2013 | 876 | 0.310 |
Why?
|
| Polymorphism, Genetic | 2 | 2001 | 201 | 0.300 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2001 | 74 | 0.290 |
Why?
|
| Female | 15 | 2026 | 24698 | 0.280 |
Why?
|
| Binding Sites | 2 | 2025 | 671 | 0.280 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1019 | 0.280 |
Why?
|
| Virion | 4 | 2016 | 75 | 0.280 |
Why?
|
| Virus Internalization | 2 | 2024 | 36 | 0.270 |
Why?
|
| Protozoan Proteins | 2 | 2004 | 191 | 0.260 |
Why?
|
| Cell Proliferation | 4 | 2022 | 1455 | 0.260 |
Why?
|
| Malaria, Cerebral | 3 | 2013 | 30 | 0.250 |
Why?
|
| Amino Acid Motifs | 3 | 2013 | 97 | 0.240 |
Why?
|
| Plant Lectins | 1 | 2025 | 8 | 0.230 |
Why?
|
| AIDS Dementia Complex | 2 | 2017 | 116 | 0.230 |
Why?
|
| Surface Plasmon Resonance | 1 | 2025 | 42 | 0.230 |
Why?
|
| Antiviral Agents | 2 | 2024 | 195 | 0.230 |
Why?
|
| Selection, Genetic | 1 | 2025 | 75 | 0.220 |
Why?
|
| Jurkat Cells | 6 | 2010 | 87 | 0.220 |
Why?
|
| Biomedical Research | 4 | 2019 | 502 | 0.210 |
Why?
|
| Trypanosomiasis, African | 1 | 2004 | 22 | 0.210 |
Why?
|
| In Situ Nick-End Labeling | 4 | 2008 | 138 | 0.200 |
Why?
|
| Molecular Chaperones | 1 | 2024 | 70 | 0.200 |
Why?
|
| Exons | 2 | 2001 | 92 | 0.200 |
Why?
|
| Endothelial Cells | 3 | 2013 | 329 | 0.200 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2024 | 245 | 0.190 |
Why?
|
| RNA, Viral | 3 | 2025 | 321 | 0.190 |
Why?
|
| Trypanosoma brucei brucei | 1 | 2004 | 82 | 0.190 |
Why?
|
| Staphylococcus aureus | 1 | 2024 | 94 | 0.190 |
Why?
|
| Plants, Medicinal | 1 | 2023 | 57 | 0.190 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 224 | 0.190 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2016 | 458 | 0.180 |
Why?
|
| DNA, Viral | 6 | 2001 | 311 | 0.180 |
Why?
|
| Mice | 13 | 2020 | 6644 | 0.180 |
Why?
|
| Protein Transport | 3 | 2014 | 296 | 0.180 |
Why?
|
| HLA Antigens | 1 | 2001 | 27 | 0.180 |
Why?
|
| Biofilms | 1 | 2024 | 184 | 0.180 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 32 | 0.180 |
Why?
|
| Animals | 20 | 2020 | 16992 | 0.170 |
Why?
|
| Mutant Proteins | 2 | 2012 | 51 | 0.170 |
Why?
|
| Brain | 3 | 2011 | 1472 | 0.170 |
Why?
|
| Cell Movement | 2 | 2022 | 655 | 0.160 |
Why?
|
| Gene Products, vpr | 1 | 2000 | 5 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2026 | 968 | 0.160 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 432 | 0.160 |
Why?
|
| Protein Kinase C | 1 | 2000 | 124 | 0.160 |
Why?
|
| Heterozygote | 1 | 1999 | 110 | 0.150 |
Why?
|
| Palmitic Acid | 1 | 2019 | 23 | 0.150 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 1998 | 1 | 0.150 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2019 | 34 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2005 | 512 | 0.150 |
Why?
|
| Behavioral Research | 1 | 2019 | 41 | 0.140 |
Why?
|
| Stem Cells | 2 | 2020 | 152 | 0.140 |
Why?
|
| Mutation | 6 | 2025 | 1177 | 0.140 |
Why?
|
| Minority Health | 1 | 2019 | 95 | 0.140 |
Why?
|
| Simplexvirus | 4 | 1984 | 11 | 0.140 |
Why?
|
| Cerebral Cortex | 1 | 2000 | 306 | 0.140 |
Why?
|
| Flow Cytometry | 3 | 2008 | 411 | 0.140 |
Why?
|
| Antigens, CD34 | 2 | 2015 | 19 | 0.140 |
Why?
|
| Gene Products, rev | 1 | 1997 | 4 | 0.140 |
Why?
|
| Rural Population | 2 | 1999 | 373 | 0.140 |
Why?
|
| Gene Expression | 2 | 2017 | 701 | 0.130 |
Why?
|
| Genes, Reporter | 1 | 1997 | 148 | 0.130 |
Why?
|
| Leptospirosis | 1 | 1997 | 31 | 0.130 |
Why?
|
| HIV | 1 | 2017 | 100 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2014 | 403 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2017 | 883 | 0.130 |
Why?
|
| Base Sequence | 7 | 1999 | 983 | 0.130 |
Why?
|
| Signal Transduction | 3 | 2019 | 2157 | 0.130 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 1996 | 117 | 0.130 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 108 | 0.120 |
Why?
|
| Adult Stem Cells | 1 | 2016 | 12 | 0.120 |
Why?
|
| Male | 13 | 2016 | 23409 | 0.120 |
Why?
|
| Ultracentrifugation | 1 | 2016 | 14 | 0.120 |
Why?
|
| Drug Carriers | 1 | 2017 | 174 | 0.120 |
Why?
|
| Caspase 3 | 2 | 2009 | 227 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2019 | 434 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 80 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2015 | 536 | 0.120 |
Why?
|
| Antigens, CD | 1 | 2016 | 127 | 0.110 |
Why?
|
| Heme | 1 | 2015 | 72 | 0.110 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 65 | 0.110 |
Why?
|
| Drug Resistance, Viral | 3 | 2005 | 67 | 0.110 |
Why?
|
| China | 1 | 2015 | 229 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 1869 | 0.110 |
Why?
|
| Database Management Systems | 1 | 2014 | 19 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 423 | 0.110 |
Why?
|
| Qa-SNARE Proteins | 1 | 2014 | 9 | 0.110 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 1 | 2014 | 9 | 0.110 |
Why?
|
| Gene Expression Regulation | 4 | 2015 | 1070 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 310 | 0.110 |
Why?
|
| Malaria, Falciparum | 1 | 2015 | 90 | 0.110 |
Why?
|
| Parietal Cells, Gastric | 1 | 2014 | 19 | 0.110 |
Why?
|
| Neovascularization, Pathologic | 1 | 2015 | 139 | 0.110 |
Why?
|
| Cyclosporine | 2 | 2005 | 36 | 0.110 |
Why?
|
| Adipose Tissue | 1 | 2016 | 182 | 0.110 |
Why?
|
| Transcription, Genetic | 3 | 1999 | 592 | 0.100 |
Why?
|
| Cytoskeletal Proteins | 1 | 2014 | 116 | 0.100 |
Why?
|
| Cell Nucleolus | 1 | 1993 | 11 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2015 | 158 | 0.100 |
Why?
|
| Genotype | 3 | 2001 | 800 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1271 | 0.100 |
Why?
|
| Cooperative Behavior | 2 | 2023 | 269 | 0.100 |
Why?
|
| Minority Groups | 1 | 2019 | 690 | 0.100 |
Why?
|
| Genes, myc | 1 | 1993 | 31 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2015 | 183 | 0.100 |
Why?
|
| Chemokine CXCL12 | 3 | 2009 | 32 | 0.100 |
Why?
|
| United States | 4 | 2019 | 5205 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2014 | 341 | 0.100 |
Why?
|
| Colonic Neoplasms | 1 | 2015 | 223 | 0.100 |
Why?
|
| Databases as Topic | 1 | 2012 | 25 | 0.100 |
Why?
|
| Chemokine CCL5 | 3 | 2007 | 41 | 0.100 |
Why?
|
| Sequence Alignment | 2 | 2012 | 272 | 0.100 |
Why?
|
| Software | 1 | 2014 | 236 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 189 | 0.100 |
Why?
|
| Antimalarials | 1 | 2013 | 64 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2005 | 247 | 0.090 |
Why?
|
| Haplotypes | 1 | 2013 | 197 | 0.090 |
Why?
|
| Healthcare Disparities | 2 | 2008 | 590 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2024 | 279 | 0.090 |
Why?
|
| Computational Biology | 1 | 2014 | 327 | 0.090 |
Why?
|
| Cell Fusion | 4 | 1984 | 19 | 0.090 |
Why?
|
| Static Electricity | 1 | 2012 | 86 | 0.090 |
Why?
|
| Entamoeba | 1 | 1992 | 3 | 0.090 |
Why?
|
| Genome, Human | 1 | 2013 | 144 | 0.090 |
Why?
|
| DNA Fragmentation | 2 | 2004 | 98 | 0.090 |
Why?
|
| Molecular Epidemiology | 2 | 2003 | 59 | 0.090 |
Why?
|
| Neuroglia | 2 | 2013 | 133 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 78 | 0.090 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 182 | 0.090 |
Why?
|
| Speech Acoustics | 1 | 2011 | 1 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 506 | 0.090 |
Why?
|
| Deafness | 1 | 2011 | 7 | 0.090 |
Why?
|
| Telephone | 1 | 2011 | 36 | 0.090 |
Why?
|
| Amino Acids | 1 | 2012 | 148 | 0.090 |
Why?
|
| Speech Perception | 1 | 2011 | 13 | 0.090 |
Why?
|
| Thermodynamics | 1 | 2012 | 229 | 0.090 |
Why?
|
| Research | 1 | 2012 | 181 | 0.090 |
Why?
|
| HIV-2 | 2 | 2004 | 9 | 0.090 |
Why?
|
| Adult | 6 | 2015 | 13872 | 0.080 |
Why?
|
| Prevalence | 1 | 2015 | 1612 | 0.080 |
Why?
|
| Plasmodium berghei | 1 | 2011 | 34 | 0.080 |
Why?
|
| Interleukin-2 | 1 | 2011 | 91 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 78 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2011 | 87 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2012 | 188 | 0.080 |
Why?
|
| Genomics | 1 | 2013 | 293 | 0.080 |
Why?
|
| DNA | 2 | 1998 | 592 | 0.080 |
Why?
|
| Chemokines, CXC | 2 | 2000 | 36 | 0.080 |
Why?
|
| Protein Sorting Signals | 1 | 2010 | 25 | 0.080 |
Why?
|
| Cohort Studies | 1 | 2014 | 1759 | 0.080 |
Why?
|
| Choroidal Neovascularization | 1 | 2009 | 5 | 0.080 |
Why?
|
| Angiogenic Proteins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2009 | 18 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 830 | 0.080 |
Why?
|
| Language | 1 | 2011 | 185 | 0.080 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2009 | 81 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 209 | 0.070 |
Why?
|
| Caspases | 2 | 2013 | 148 | 0.070 |
Why?
|
| Caspase 9 | 1 | 2009 | 30 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2010 | 296 | 0.070 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2853 | 0.070 |
Why?
|
| Ligands | 2 | 2000 | 388 | 0.070 |
Why?
|
| HIV Antibodies | 1 | 1988 | 24 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1081 | 0.070 |
Why?
|
| Infant | 3 | 2007 | 1175 | 0.070 |
Why?
|
| DNA Transposable Elements | 2 | 1999 | 55 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 863 | 0.070 |
Why?
|
| Porphyromonas gingivalis | 2 | 1999 | 40 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 267 | 0.070 |
Why?
|
| Phylogeny | 3 | 2003 | 769 | 0.070 |
Why?
|
| Georgia | 2 | 1999 | 192 | 0.070 |
Why?
|
| Diffusion of Innovation | 1 | 2008 | 38 | 0.070 |
Why?
|
| Erythrocytes | 1 | 2008 | 126 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2004 | 694 | 0.070 |
Why?
|
| Middle Aged | 4 | 2015 | 12222 | 0.070 |
Why?
|
| Interinstitutional Relations | 1 | 2008 | 51 | 0.070 |
Why?
|
| Adolescent | 2 | 2015 | 6081 | 0.070 |
Why?
|
| Transformation, Genetic | 1 | 1987 | 20 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 201 | 0.070 |
Why?
|
| Thymus Gland | 1 | 2008 | 76 | 0.070 |
Why?
|
| Aged | 3 | 2015 | 8214 | 0.070 |
Why?
|
| Plasmodium falciparum | 1 | 2008 | 144 | 0.060 |
Why?
|
| Young Adult | 2 | 2015 | 5080 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 1596 | 0.060 |
Why?
|
| Recombination, Genetic | 2 | 2004 | 95 | 0.060 |
Why?
|
| Temperature | 3 | 2004 | 313 | 0.060 |
Why?
|
| Genes, Viral | 2 | 1982 | 61 | 0.060 |
Why?
|
| Cytopathogenic Effect, Viral | 3 | 1982 | 14 | 0.060 |
Why?
|
| Genes, nef | 1 | 2005 | 5 | 0.060 |
Why?
|
| Glycosylation | 1 | 2025 | 113 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2015 | 1546 | 0.060 |
Why?
|
| Neoplasms, Experimental | 1 | 2005 | 38 | 0.060 |
Why?
|
| Disease Progression | 2 | 2015 | 667 | 0.060 |
Why?
|
| Transplantation, Heterologous | 1 | 2005 | 98 | 0.060 |
Why?
|
| HIV Fusion Inhibitors | 1 | 2024 | 5 | 0.050 |
Why?
|
| Simian immunodeficiency virus | 1 | 2005 | 60 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 455 | 0.050 |
Why?
|
| Viral Regulatory and Accessory Proteins | 1 | 2004 | 9 | 0.050 |
Why?
|
| Endopeptidases | 1 | 2004 | 64 | 0.050 |
Why?
|
| Brain Stem | 1 | 2004 | 52 | 0.050 |
Why?
|
| Cerebellum | 1 | 2004 | 79 | 0.050 |
Why?
|
| Triazoles | 1 | 2024 | 102 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2004 | 109 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 1984 | 91 | 0.050 |
Why?
|
| Barbados | 2 | 2003 | 3 | 0.050 |
Why?
|
| Plant Proteins | 1 | 2023 | 102 | 0.050 |
Why?
|
| Rats | 2 | 2019 | 3735 | 0.040 |
Why?
|
| Umbilical Veins | 1 | 2001 | 19 | 0.040 |
Why?
|
| Child | 3 | 2015 | 3443 | 0.040 |
Why?
|
| Hela Cells | 2 | 2004 | 376 | 0.040 |
Why?
|
| Phorbol Esters | 1 | 2000 | 8 | 0.040 |
Why?
|
| Genes, pol | 1 | 2000 | 15 | 0.040 |
Why?
|
| Sphingosine | 1 | 2000 | 22 | 0.040 |
Why?
|
| Schools | 1 | 2023 | 283 | 0.040 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2000 | 45 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 1997 | 2544 | 0.040 |
Why?
|
| Neurons | 2 | 2015 | 1263 | 0.040 |
Why?
|
| GTP-Binding Proteins | 1 | 2000 | 59 | 0.040 |
Why?
|
| vpr Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 8 | 0.040 |
Why?
|
| Coloring Agents | 1 | 2000 | 55 | 0.040 |
Why?
|
| Hindlimb | 1 | 2020 | 32 | 0.040 |
Why?
|
| Necrosis | 1 | 2000 | 54 | 0.040 |
Why?
|
| Ischemia | 1 | 2020 | 47 | 0.040 |
Why?
|
| Chemokine CCL4 | 1 | 1999 | 19 | 0.040 |
Why?
|
| Hemagglutinins | 1 | 1999 | 9 | 0.040 |
Why?
|
| Rabbits | 2 | 2014 | 278 | 0.040 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 1999 | 16 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2000 | 462 | 0.040 |
Why?
|
| Adhesins, Bacterial | 1 | 1999 | 21 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 1999 | 109 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2022 | 302 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 1999 | 64 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2009 | 1092 | 0.040 |
Why?
|
| Blood-Brain Barrier | 2 | 2013 | 173 | 0.040 |
Why?
|
| DNA Fingerprinting | 1 | 1998 | 16 | 0.040 |
Why?
|
| Homozygote | 1 | 1998 | 77 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 89 | 0.040 |
Why?
|
| Public Health | 1 | 2023 | 424 | 0.040 |
Why?
|
| Ghana | 2 | 2007 | 36 | 0.040 |
Why?
|
| Astrocytes | 1 | 2000 | 244 | 0.030 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 1 | 1997 | 3 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1997 | 31 | 0.030 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 55 | 0.030 |
Why?
|
| Luciferases | 1 | 1997 | 71 | 0.030 |
Why?
|
| Leptospira | 1 | 1997 | 27 | 0.030 |
Why?
|
| Homosexuality | 1 | 1997 | 36 | 0.030 |
Why?
|
| Research Personnel | 1 | 2019 | 206 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2019 | 193 | 0.030 |
Why?
|
| Viral Proteins | 3 | 1984 | 190 | 0.030 |
Why?
|
| Sex Distribution | 1 | 1997 | 224 | 0.030 |
Why?
|
| Pregnancy | 2 | 1996 | 1772 | 0.030 |
Why?
|
| Morphine | 1 | 2017 | 69 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 1997 | 238 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2000 | 1124 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1997 | 113 | 0.030 |
Why?
|
| Virus Replication | 3 | 2008 | 318 | 0.030 |
Why?
|
| Heterosexuality | 1 | 1997 | 97 | 0.030 |
Why?
|
| Hippocampus | 1 | 2000 | 594 | 0.030 |
Why?
|
| Substance Abuse, Intravenous | 1 | 1997 | 129 | 0.030 |
Why?
|
| Cell Count | 2 | 2013 | 145 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 206 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 8 | 0.030 |
Why?
|
| Microvessels | 1 | 2016 | 31 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2015 | 49 | 0.030 |
Why?
|
| Microcirculation | 1 | 2015 | 40 | 0.030 |
Why?
|
| Methamphetamine | 1 | 2017 | 166 | 0.030 |
Why?
|
| Down-Regulation | 1 | 1997 | 456 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2015 | 129 | 0.030 |
Why?
|
| Time Factors | 1 | 2000 | 1857 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 88 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2009 | 125 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 1766 | 0.030 |
Why?
|
| Cocaine | 1 | 2017 | 251 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 408 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2014 | 74 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 237 | 0.030 |
Why?
|
| Genetic Complementation Test | 2 | 2005 | 56 | 0.030 |
Why?
|
| Viral Load | 1 | 2015 | 348 | 0.030 |
Why?
|
| MyoD Protein | 1 | 1993 | 9 | 0.030 |
Why?
|
| RNA, Antisense | 1 | 1993 | 18 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1993 | 64 | 0.030 |
Why?
|
| Heptanoic Acids | 1 | 2013 | 12 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 1993 | 25 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 1993 | 138 | 0.020 |
Why?
|
| Muscle Proteins | 1 | 1993 | 51 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 1996 | 972 | 0.020 |
Why?
|
| Artemisinins | 1 | 2013 | 19 | 0.020 |
Why?
|
| Heme Oxygenase-1 | 1 | 2013 | 52 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1993 | 154 | 0.020 |
Why?
|
| Pyrroles | 1 | 2013 | 72 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2013 | 150 | 0.020 |
Why?
|
| Leukocytes | 1 | 2013 | 80 | 0.020 |
Why?
|
| Kinetics | 3 | 1987 | 695 | 0.020 |
Why?
|
| Actins | 1 | 1993 | 164 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1285 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1993 | 136 | 0.020 |
Why?
|
| Health Status Disparities | 1 | 2019 | 719 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 2013 | 154 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 1993 | 508 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 1992 | 7 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2013 | 368 | 0.020 |
Why?
|
| Phonetics | 1 | 2011 | 6 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 986 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 1993 | 383 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 78 | 0.020 |
Why?
|
| RNA | 1 | 1993 | 266 | 0.020 |
Why?
|
| Laser Coagulation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Vitreous Body | 1 | 2009 | 10 | 0.020 |
Why?
|
| Injections | 1 | 2009 | 42 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 60 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 1993 | 561 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 509 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2013 | 561 | 0.020 |
Why?
|
| Risk Factors | 1 | 1997 | 3994 | 0.020 |
Why?
|
| Nigeria | 1 | 1988 | 92 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2009 | 100 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 652 | 0.020 |
Why?
|
| Canada | 1 | 1988 | 163 | 0.020 |
Why?
|
| Leukemia, Experimental | 1 | 1987 | 4 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1987 | 27 | 0.020 |
Why?
|
| E-Selectin | 1 | 2007 | 23 | 0.020 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2007 | 15 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 17 | 0.020 |
Why?
|
| Genes | 1 | 1987 | 56 | 0.020 |
Why?
|
| Adenine Phosphoribosyltransferase | 1 | 1987 | 1 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2008 | 181 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 1987 | 9 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2007 | 74 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2009 | 347 | 0.020 |
Why?
|
| Chemokines, CC | 1 | 2007 | 55 | 0.020 |
Why?
|
| Immunoassay | 1 | 2007 | 74 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 1987 | 46 | 0.020 |
Why?
|
| Health Services Research | 1 | 2008 | 161 | 0.020 |
Why?
|
| Survival Rate | 1 | 2007 | 355 | 0.020 |
Why?
|
| Lung | 1 | 2009 | 492 | 0.020 |
Why?
|
| Cloning, Molecular | 2 | 1984 | 314 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2008 | 232 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2007 | 384 | 0.010 |
Why?
|
| Chimera | 1 | 2005 | 18 | 0.010 |
Why?
|
| Prognosis | 1 | 2007 | 861 | 0.010 |
Why?
|
| Cyclophilin A | 1 | 2004 | 19 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1984 | 197 | 0.010 |
Why?
|
| Genetic Markers | 1 | 1984 | 150 | 0.010 |
Why?
|
| HIV Protease | 1 | 2003 | 23 | 0.010 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2003 | 35 | 0.010 |
Why?
|
| Glycopeptides | 1 | 1982 | 14 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2003 | 515 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 430 | 0.010 |
Why?
|
| Virulence | 1 | 1999 | 246 | 0.010 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1987 | 8 | 0.000 |
Why?
|
| Cricetinae | 1 | 1987 | 241 | 0.000 |
Why?
|
| Plasmids | 1 | 1987 | 244 | 0.000 |
Why?
|
| Chickens | 1 | 1987 | 161 | 0.000 |
Why?
|